Thyrotoxicosis with toxic multinodular goiter
ICD-10 E05.2 is a billable code used to indicate a diagnosis of thyrotoxicosis with toxic multinodular goiter.
Thyrotoxicosis with toxic multinodular goiter is a condition characterized by the excessive production of thyroid hormones due to the presence of multiple hyperfunctioning nodules within the thyroid gland. This condition is often a result of long-standing iodine deficiency or autonomous nodular growth, leading to hyperthyroidism. Patients may present with symptoms such as weight loss, increased appetite, heat intolerance, palpitations, and anxiety. Physical examination may reveal a visibly enlarged thyroid gland (goiter) with multiple nodules. Diagnosis is typically confirmed through thyroid function tests, which show elevated levels of free thyroxine (FT4) and triiodothyronine (FT3), alongside suppressed thyroid-stimulating hormone (TSH) levels. Imaging studies, such as ultrasound, may be utilized to assess the size and characteristics of the nodules. Management often involves antithyroid medications, radioactive iodine therapy, or surgical intervention, depending on the severity of symptoms and the size of the goiter.
Thorough documentation of thyroid function tests, imaging results, and treatment plans.
Patients presenting with symptoms of hyperthyroidism and a palpable goiter.
Endocrinologists must ensure that all relevant lab results are included in the patient's record to support the diagnosis.
Detailed patient history, symptom assessment, and referral notes to specialists if necessary.
Initial evaluation of patients with unexplained weight loss, anxiety, or palpitations.
Primary care providers should be aware of the need for timely referrals to endocrinology for further evaluation.
Used to assess thyroid function in patients suspected of having E05.2.
Document the reason for the test and the results.
Endocrinologists should ensure that TSH levels are interpreted in the context of FT4 and FT3 levels.
Performed to evaluate the size and characteristics of thyroid nodules.
Include ultrasound findings in the patient's record.
Documentation should specify the number and size of nodules.
Common symptoms include weight loss, increased appetite, heat intolerance, palpitations, anxiety, and fatigue. Patients may also present with a visibly enlarged thyroid gland.
Diagnosis is made through thyroid function tests showing elevated FT4 and FT3 levels with suppressed TSH, along with imaging studies to assess the presence of multinodular goiter.
